Skip to content

A prospective study of papaverine hydrochloride combined with ultrahigh pressure angiography to improve the positive rate of angiography in patients with upper gastrointestinal bleeding after endoscopic intervention

A prospective study of papaverine hydrochloride combined with ultrahigh pressure angiography to improve the positive rate of angiography in patients with upper gastrointestinal bleeding after endoscopic intervention

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068567
Enrollment
Unknown
Registered
2023-02-23
Start date
2023-02-27
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal bleeding

Interventions

research group:Ultrahigh pressure angiography was performed after injection of 30mg papaverine hydrochloride

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 100 Years

Inclusion criteria

Inclusion criteria: Gastroscopic examination of patients with upper gastrointestinal bleeding showed that Forrest was rated Ia, Ib, or IIa, and at least one of the following bleeding manifestations occurred again after gastroscopic diagnosis and treatment: (1) The number of hematemesis or black stool is increased, the vomit is bright red or discharge dark red stool or accompanied by active bowel sound; (2) After rapid infusion and blood transfusion, peripheral circulatory failure showed no obvious improvement or worsened after temporary improvement, the central venous pressure still fluctuated slightly stable and then declined again; ? Red blood cell count, hemoglobin concentration and hematocrit continued to decrease, while reticulocyte count continued to increase; (4) Blood urea nitrogen increased continuously or again under the condition of sufficient fluid and urine volume; (5) More new blood was extracted from gastric tube; (6)Active bleeding was found to be unable to stop bleeding under endoscopy. These patients underwent routine hypertensive angiography and were enrolled in the study if the angiography was negative

Exclusion criteria

Exclusion criteria: ? Pregnant or lactating patients; ? the dying patient; ? Patients with advanced malignant disease or other advanced malignant disease with limited life expectancy; ? Patients who are allergic to contrast agent or papaverine hydrochloride; ? Patients who could not cooperate with or refused interventional treatment.

Design outcomes

Primary

MeasureTime frame
Positive rate of angiography;

Secondary

MeasureTime frame
Complication rates;Rebleeding rate;

Countries

china

Contacts

Public Contactzhongjiawei

The First Affiliated Hospital of Nanchang University

512286698@qq.com13870958291

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026